Laxacin

Product NDC: 50488-0901
11-digit product format: 504880901
Labeler code: 50488
Product ID: 50488-0901_1b45f6d1-4436-4b3a-813b-7043c0d0fad6
Type: HUMAN OTC DRUG
Nonproprietary name: Docusate sodium and sennosides
Dosage form: TABLET
Route: ORAL
Labeler: Alexso, Inc
Application: M007
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2018-10-15
Substance: DOCUSATE SODIUM; SENNOSIDES A AND B
Active strength: 50; 8.6 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Laxacin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOCUSATE SODIUM	50 mg/1
SENNOSIDES A AND B	8.6 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F05Q2T2JA0	Internal UNII lookup
1B5FPI42EN	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
998740	Internal RxNorm lookup
2106884	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0df9abaf-3997-4dde-8003-ae3d8d07cf39	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50488-0901-1	Laxacin	100 in 1 BOTTLE	TABLET	100		8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50488-0901-1	EA - Each	50488-0901	933d71c3-b01d-44ff-b256-0bee20827ae8	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DOCUSATE	ACTIVE MOIETY	M7P27195AG	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SENNOSIDES A AND B	ACTIVE MOIETY	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
DOCUSATE	ACTIVE MOIETY	M7P27195AG	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50488-0901	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO, INC]	8	Current NDC, Legacy NDC, 1 package rows	20241208_0df9abaf-3997-4dde-8003-ae3d8d07cf39.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 9 of 43 · 858 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glycerin	GLYCERIN	Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd	4c6094b7-c1ef-26a3-e063-6394a90af4cc	2026-03-06	Warnings	Exact identifier application number: M007
Stool Softener plus Stimulant Laxative	DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG	CARDINAL HEALTH, 110 DBA LEADER	3fd9ba76-42f8-4ebe-b1bc-f81f08e702ce	2026-03-06	Warnings	Exact identifier application number: M007
Magnesium Citrate	EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON	Walmart Inc.	484d0421-59ea-3783-e063-6394a90af633	2026-03-04	Warnings	Exact identifier application number: M007
Magnesium Citrate	EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY	Walmart Inc.	484c2586-9e6f-1ce5-e063-6394a90a0d81	2026-03-04	Warnings	Exact identifier application number: M007
Magnesium Citrate	EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE	Walmart Inc.	450ddcbd-7ccd-3670-e063-6294a90ac2bd	2026-03-04	Warnings	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Amazon.com Services LLC	787ec4b0-c6c5-44ab-a53d-d6d25304f95e	2026-03-03	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Old East Main Co.	3d0d63d7-640d-4e54-a6fd-6b265c79be09	2026-03-02	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Old East Main Co.	9b3b6cea-ab83-4b7c-a425-fd0ac7df426c	2026-03-02	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Old East Main Co.	51ed515b-cc51-4ea1-b612-090476135005	2026-03-02	Warnings, Adverse reactions	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Old East Main Co.	a8af6e2d-0052-4fc9-a51a-c9dbeb1ad3f5	2026-03-02	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Chain Drug Marketing Association	629c5817-13b7-4527-8998-93131ee3529e	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Chain Drug Marketing Association	4df97cdc-e7a2-4350-8f95-a679cdcaff64	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Chain Drug Marketing Association	46b26b44-e065-4337-a071-fa036f897140	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	Chain Drug Marketing Association	ef163b24-ce92-4cbc-b45a-4fae3b511949	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Chain Drug Marketing Association	4ee26633-8eb1-4c68-a768-20460404533a	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Mineral Oil	MINERAL OIL	Chain Drug Marketing Association	3bfdad9c-ac58-4e92-b952-555e8a8351cd	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	The Kroger Co.	2bcab227-42b6-4bff-8363-f6800665755b	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	The Kroger Co.	a87dceb2-da73-4d3a-b87c-db2af10471bf	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Sunscreen	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	The Kroger Co.	3ae7e275-7bbc-4e62-b30f-013c40a89949	2026-02-27	Warnings	Exact identifier application number: M007
Sennosides	SENNOSIDES	CVS Pharmacy, Inc	0b7736df-c7de-7d00-e063-6294a90aa57e	2026-02-26	Warnings	Exact identifier application number: M007

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM
1B5FPI42EN	SENNOSIDES A AND B	62211-03-4	SENNOSIDES A AND B

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	PSN	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
2106884	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SBD	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
2106884	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SY	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	SY	0df9abaf-3997-4dde-8003-ae3d8d07cf39	8
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	PSN	57fca238-ba1e-4b05-abda-a8333da8132a	2
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	PSN	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	57fca238-ba1e-4b05-abda-a8333da8132a	2
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
2106884	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SBD	57fca238-ba1e-4b05-abda-a8333da8132a	2
2106884	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SBD	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	57fca238-ba1e-4b05-abda-a8333da8132a	2
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	57fca238-ba1e-4b05-abda-a8333da8132a	2
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
2106884	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SY	57fca238-ba1e-4b05-abda-a8333da8132a	2
2106884	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Laxacin]	SY	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	SY	57fca238-ba1e-4b05-abda-a8333da8132a	2
2106884	Laxacin 50 MG / 8.6 MG Oral Tablet	SY	fe7d4d75-0f8a-1e7d-e053-6394a90afb4d	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50488-0901-1	50488090101	100 TABLET in 1 BOTTLE (50488-0901-1)	100 tablet	2018-10-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Laxacin Tablets	Advanced Rx Pharmacy of Tennessee, LLC	2024-12-31	HUMAN OTC DRUG LABEL	2
Laxacin Laxative Plus Stool Softener	Alexso, Inc	2024-12-04	HUMAN OTC DRUG LABEL	8
Laxacin Laxative Plus Stool Softener	Quality Care Products, LLC	2023-12-21	HUMAN OTC DRUG LABEL	2
LAXACIN	Direct_Rx	2023-10-06	HUMAN OTC DRUG LABEL	3
Laxacin Laxative Plus Stool Softener	NuCare Pharmaceuticals,Inc.	2021-02-11	HUMAN OTC DRUG LABEL	5
Laxacin Laxative Plus Stool Softener	medsource pharmaceuticals	2018-12-20	HUMAN OTC DRUG LABEL	2
LAXACIN	DIRECT RX	2018-03-26	HUMAN OTC DRUG LABEL	1
Laxacin Laxative Plus Stool Softener	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2013-07-12	HUMAN OTC DRUG LABEL	2